fashion -WSS

fashion

author：entertainment 2025-10-02 01:12:36 - browse：769

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Why the advice to take all your antibiotics may be wrong

explore

WSS

How to fix the rural physician shortage in the U.S.

What is artificial intelligence? Experts weigh in

Biden White House, tech companies launch new safeguards around emerging AI technology

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Can medical device makers keep up in the race to treat obesity?

EMA weighs against approval for Mirati's lung cancer drug

entertainment

fashion

leisure time

Psychedelics group wrestles with new pharma identity

Novo: Oral version of Ozempic leads to 15% weight loss

Continuity nursing helped my family in our darkest PICU moments

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Virginia high school admissions case could be legal follow

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Sports medicine is finally prioritizing gender equality

'The View' co

Alkermes shareholders re

Why the advice to take all your antibiotics may be wrong

leisure time

FDA approves first new drug developed for postpartum depression

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Listen: BridgeBio's big week & Lilly's Alzheimer's data

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Living organ donors deserve priority status for transplants

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

hotspot

explore

hotspot